Post

New research · Ophthalmology
Cancers · 1d
Cohort studyCancers · 2026

Comparison of MOLES and Mel AI noma for Differentiating Small Choroidal Melanomas from Nevi.

Katerina Stripling, Hannah Coudé Adam, Mats Holmström, Gustav Stålhammar
Read paper
OphthalmologyCohort study

AI algorithm Mel AI noma more strongly linked to melanoma diagnosis than MOLES score

Comparison of MOLES and Mel AI noma for Differentiating Small Choroidal Melanomas from Nevi.

Katerina Stripling … Gustav Stålhammar
Cancers · 2026
Background

Early identification of small choroidal melanomas is important, as metastatic risk increases with tumor size.

Purpose

This study aims to compare the association between MOLES and Mel AI noma scores and to assess their relative association with expert melanoma versus nevus diagnosis.

Methods

In this retrospective cohort study, 86 patients with small pigmented choroidal lesions (29 melanomas and 57 nevi) diagnosed at a national ocular oncology referral center were included.

n = 86 patients
Results

Mel AI noma's score predicts a melanoma diagnosis better than MOLES score does

0.38R²
Mel AI noma
0.27R²
MOLES
More results

Mel AI noma scores increased monotonically with higher MOLES categories ( p = 0.0001).

In univariable logistic regression, both MOLES and Mel AI noma scores were associated with increased odds of melanoma diagnosis.

In multivariable analysis including both scores, each remained independently associated with melanoma diagnosis.

“
Conclusion · 1 of 2

Both MOLES and Mel AI noma are effective for differentiating small choroidal melanomas from nevi. Although the scores are statistically associated, they capture partly distinct information.

Conclusion · 2 of 2

Mel AI noma demonstrates slightly stronger association with melanoma diagnosis and provides fully reproducible output, supporting its role as a complementary aid in lesion triage.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment